Newer anti-epileptic drugs

Indian Journal of Pediatrics

Volumn 63, Issue 2, 1996, Pages 233-241

  Aneja, S ^a,b   Newton, R W ^a  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

antiepileptic drugs; Felbamate; Gabapentin; Lamotrigine; Oxcarbazepine; Vigabatrin

Indexed keywords

ANTICONVULSIVE AGENT; FELBAMATE; GABAPENTIN; LAMOTRIGINE; NEW DRUG; OXCARBAZEPINE; VIGABATRIN;

CHILD; CHILDHOOD DISEASE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; EPILEPSY; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; REVIEW;

EID: 0029989798     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02845250     Document Type: Review

References (37)

1. Rey E, Pons G, Olive G. Vigabatrin-Clinical Pharmacokinetics. Clin Pharmacokinet 1992; 23 : 267-78.
2. Arteaga R, Herranz JL, Valdizan EM, Armijo JA. Gammavinyl GABA (Vigabatrin) : relationship between dosage, plasma concentration, platelet GABA transaminase inhibition and seizure reduction in epileptic children. Epilepsia 1992; 33 (5) : 923-931.
3. Mumford JP, Dam M. Meta-analysis of European placebo controlled studies of Vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol 1989; 27 (1) : 101-107.
4. Gram L, Saber A, Dulac O. Treatment of pediatric epilepsies with gamma-vinyl GABA (Vigabatrin). Epilepsia 1992; 33 (5) : 26-29.
5. Uldall P, Alving J, Gram L, Beck S. Vigabatrin in pediatric epilepsy - an open study. J Child Neurol 1991; (2) : 38-44.
6. Gibbs JM, Appleton RE, Rosenbloom L. Vigabatrin in intractable childhood epilepsy - a retrospective study. Pediatric Neurol 1992; 8 : 338-340.
7. Dulac O, Chiron C, Cusmai R et al. Vigabatrin in childhood epilepsy. J Child Neurol 1991; (2) : 30-47.
8. Chiron C, Dulac O, Beaumont D et al. Therapeutic trial of Vigabatrin in refractory infantile spasms. J Child Neurol 1991; (2) : 52-59.
9. Vles JS, Van-der Heyden AM, Ghijs A, Troost J. Vigabatrin in the treatment of infantile spasms. Neuropediatrics 1993; 24 (4) : 230-231.
10. Fencht M, Brantner-Iuthaler S. Gammavinyl-GABA (Vigabatrin) in the therapy of Lennox-Gastaut Syndrome : an open study. Epilepsia 1994; 35 : 993-998.
11. Leach MJ, Baxter MC, Critchely. Neurochemical and Behavioural aspects of Lamotrigine. Epilepsia 1991; 32 (2) : 4-8.
12. Brodie JM. Lamotrigine. Lancet 1992; 339 : 1397-1400.
13. Schapel CJ, Beram RG, Vajda FJ et al. Double blind placebo controlled crossover study of Lamotrigine in treatment resistant seizure. J Neurol Neurosurg Psychiatry 1993; 56 : 448-453.
14. Messenheimer J, Ramsay RE, Willmore LJ et al. Lamotrigine therapy for partial seizure - a multicentered placebo controlled double blind crossover trial. Epilepsia 1994; 35 : 113-121.
15. Smith D, Baker G, Davies G et al. Outcomes of add on treatment with Lamotrigine in partial epilepsy. Epilepsia 1993; 34 (2) : 312-322.
16. Timings PL, Richen A. Lamotrigine as add on drug in management of Lennox-Gastaut syndrome. Eur Neurol 1992; 32 (6) : 305-307.
17. Gibbs J, Appleton RE, Rosenbloom L, Yuen WC. Lamotrigine for intractable childhood epilepsy - a preliminary communication. Dev Med Child Neurol 1992; 34 : 368-371.
18. Schlumeberger E, Cheva F, Palacios F et al. Lamotrigine-treatment of 120 children with epilepsy. Epilepsia 1994; 35 : 359-367.
19. Battino D, Buti D, Croci D et al. Lamotrigine in resistant childhood epilepsy. Neuropediatrics 1993, 24 (6) : 32-6.
20. Manonmani V, Wallace SJ. Epilepsy with myoclonic abscences. Arch Dis Child 1994; 70 : 228-290.
21. Uldall P, Hansen FJ, Tonnby B. Lamotrigine in Rett's syndrome. Neuropediatrics 1993; 24 : 339-340.
22. Schwab JEM, Willamson PJ, Barnes EW, Trawby PN. Multisystem adverse reaction to Lamotrigine. Lancet 1994, 344 : 481.
23. Ywen AC, Bihari DJ. Multiorgan failure and DIC in severe convulsion. Lancet 1992; 340 : 618.
24. Mcdonald RL, Kelly KM. Anti-epileptic drug-mechanism of action. Epilepsia 1993; 34 (5) : 1-8.
25. UK Gabapentin study group. Gabapentin in partial epilepsy. Lancet 1990; 335 (8698) : 1114-1117.
26. Liedermann DB. Gabapentin as add on therapy for refractory partial epilepsy-results of five placebo controlled trials. Epilepsia 1994; 35 (suppl 5) : 74-76.
27. Frmm GH. Gabapentin : discussion. Epilepsia 1994; 35 (5) : 577-580.
28. Leidermann D, Garafalo E, La Moreaux L. Gabapentin in patients with absence seizures : 2 double blind placebo controlled studies. Epilepsia 1993; 34 (6) : 45.
29. Brodie MJ. Felbamate - a new anti-epileptic drug. Lancet 1993; 341 : 1445-1446.
30. Faugnt E, Sachdeo RC, Remler MP, Chayasirisobhon S et al. Felbamate monotherapy for partial onset seizures an active control trial. Neurology 1993; 43 : 688-926.
31. Bourgeois B, Leppik IE, Sackellares JC et al. Felbamate a double blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Neurology 1993; 43 : 693-696.
32. Dodson EW. Felbamate in the treatment of Lennox-Gastaut syndrome. Results of a 12 month open label study following a randomised clinical trial. Epilepsia 1993; 34 (7) : 18-24.
33. Felbamate and aplastic anemia - News Report. Lancet 1994; 344 : 465.
34. Scwabe S. Oxcarbazepine : Clinical development program. Epilepsia 1994; 35 (5) : 51-52.
35. Friis ML, Kristenson O, Boas J, Dalby M et al. Therapeutic experiences with 947 epileptic outpatients on oxcarbazepine treatment. Acta Neurol Scand 1993; 87 : 224-227.
36. Beran RG. Cross-reactive skin eruptions with both, carbamazepine and oxcarbazapine. Epilepsia 1993; 34 : 163-165.
37. Armijo JA, Arteaga R, Valdizan EM, Herranz JL. Coadministration of Vigabatrin and Valproate in children with refractory epilepsy. J Clin Neuropharmacol 1992; 15 : 459-469.